HealthDay News — Recommendations have been developed for managing heart failure in pregnancy and published online Sept. 22 in a Society for Maternal-Fetal Medicine Consult Series in Pregnancy.
Australian scientists have developed a biosensor that can rapidly detect the heart failure biomarker S100A7 in saliva, ...
People who receive stem cell therapy within a week of their first heart attack have nearly a 60 per cent lower risk of ...
News-Medical.Net on MSN
Clinical Frailty Scale can quickly predict mortality in patients with heart failure
Frailty is closely linked to adverse outcomes in older adults, particularly those with heart failure. Numerous epidemiologic ...
News-Medical.Net on MSN
Study provides first worldwide validation of new GLIS model in older patients with heart failure
With populations aging rapidly worldwide, heart failure has become one of the most pressing medical and social challenges.
A team of physicists has developed a groundbreaking method for detecting congestive heart failure with greater ease and precision than previously thought possible. This multidisciplinary study, ...
TipRanks on MSN
Amgen’s Maridebart Cafraglutide Study: A Potential Game-Changer in Heart Failure Treatment
Amgen Inc (($AMGN)) announced an update on their ongoing clinical study. Amgen Inc. is conducting a pivotal clinical study ...
Rising greenhouse gases exacerbate cardiovascular mortality in older heart failure patients by increasing extreme temperatures. A U- or J-shaped relationship exists between nonoptimal temperatures and ...
Information provided on Forbes Advisor is for educational purposes only. Your financial situation is unique and the products and services we review may not be right for your circumstances. We do not ...
Information provided on Forbes Advisor is for educational purposes only. Your financial situation is unique and the products and services we review may not be right for your circumstances. We do not ...
Investor's Business Daily on MSN
Novartis Slips As Generics Bite Into Its Heart-Failure Drug Sales In Mixed Third Quarter
Novartis stock fell Tuesday after a mixed third-quarter report that included a sales decline for heart-failure drug Entresto.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results